NCT03142659 Evaluation and Management of Heart Failure Patients
| NCT ID | NCT03142659 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tel-Aviv Sourasky Medical Center |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2017-07-01 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2017-07-01 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigator is trying to improving our knowledge in the treatment of HF patients, for the purpose of improving their quality of life and reducing hospitalizations. For achieving this the investigator would like to build a registry which will include all the HF patients going an evaluation in the Heart Failure unit or clinic in our facility,
Eligibility Criteria
Inclusion Criteria: 1. Age ≥18 years old 2. Patient evaluated in the Heart Failure unit or clinic in our facility. 3. Approved consent. Exclusion Criteria: 1\. Patients who haven't signed the informed consent in the prospective group.
Contact & Investigator
Michal Laufer Perl, MD
PRINCIPAL INVESTIGATOR
Tel Aviv Medical Center
Frequently Asked Questions
Who can join the NCT03142659 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 120 Years, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03142659 currently recruiting?
Yes, NCT03142659 is actively recruiting participants. Contact the research team at michalpela@gmail.com for enrollment information.
Where is the NCT03142659 trial being conducted?
This trial is being conducted at Tel Aviv, Israel.
Who is sponsoring the NCT03142659 clinical trial?
NCT03142659 is sponsored by Tel-Aviv Sourasky Medical Center. The principal investigator is Michal Laufer Perl, MD at Tel Aviv Medical Center. The trial plans to enroll 5,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.